![Roland Gordon-Beresford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roland Gordon-Beresford worked as Director-IP & Regulatory Affairs at Celyad Oncology SA from 2012 to 2013.
He also worked as Chief Regulatory Affairs Officer at Novadip Biosciences SA. Dr. Gordon-Beresford holds a doctorate degree from Université Libre de Bruxelles.
| Companies | Position | End |
|---|---|---|
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | General Counsel | - |
| CELYAD ONCOLOGY SA | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
